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Abstract
Background: Staphylococcus aureus produces a set of proteins which act both as superantigens and
toxins. Although their mode of action as superantigens is well understood, little is known about
their effects on airway epithelial cells.
Methods: To investigate this problem, primary nasal epithelial cells derived from normal and
asthmatic subjects were stimulated with staphylococcal enterotoxin A and B (SEA and SEB) and
secreted (supernatants) and cell-associated (cell lysates) IL-8, TNF-α, RANTES and eotaxin were
determined by specific ELISAs.
Results: Non-toxic concentrations of SEA and SEB (0.01 μg/ml and 1.0 μg/ml) induced IL-8
secretion after 24 h of culture. Pre-treatment of the cells with IFN-γ (50 IU/ml) resulted in a further
increase of IL-8 secretion. In cells from healthy donors pretreated with IFN-γ, SEA at 1.0 μg/ml
induced release of 1009 pg/ml IL-8 (733.0–1216 pg/ml, median (range)) while in cells from asthmatic
donors the same treatment induced significantly higher IL-8 secretion – 1550 pg/ml (1168.0–2000.0
pg/ml p = 0.04). Normal cells pre-treated with IFN-γ and then cultured with SEB at 1.0 μg/ml
released 904.6 pg/ml IL-8 (666.5–1169.0 pg/ml). Cells from asthmatics treated in the same way
produced significantly higher amounts of IL-8 – 1665.0 pg/ml (1168.0–2000.0 pg/ml, p = 0.01).
Blocking antibodies to MHC class II molecules added to cultures stimulated with SEA and SEB,
reduced IL-8 secretion by about 40% in IFN-γ unstimulated cultures and 75% in IFN-γ stimulated
cultures. No secretion of TNF-α, RANTES and eotaxin was noted.
Conclusion: Staphylococcal enterotoxins may have a role in the pathogenesis of asthma.
Background
Staphylococcus aureus (S. aureus) is a common human
pathogen associated with various local and systemic infec-
tions, characterized by inflammation dominated by poly-
morphonuclear leukocytes. It produces a set of toxins
including staphylococcal enterotoxins and toxic shock
syndrome toxin-1 which cause food poisoning and toxic
shock syndrome respectively in humans and other spe-
cies. These toxins are intermediate molecular weight pro-
teins (22-20 kD) that also act as superantigens (SAgs) due
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to their ability to bind to MHC class II molecules on anti-
gen presenting cells and stimulate all T cells bearing par-
ticular V βs on their T cell receptors [1].
The epithelium acts as a physiological barrier to diffusion
[2] and after physical or chemical damage has occurred,
inhaled allergens, irritants and agonists can have detri-
mental effects on the underlying smooth muscle [3]. Tra-
ditionally, the epithelium was considered to be an inert
barrier dividing the external environment and the inner
tissue of the lung. However, it is now accepted that it con-
stitutes the interface between the internal milieu and the
external environment and plays a pivotal role in control-
ling many airway functions including barrier and secre-
tory functions [4-6]. Airway hyper-responsiveness and
epithelial cell damage are associated commonly with
asthma.
In view of the ever increasing evidence for the effects of
staphylococcal superantigens on immuno-modulatory
and pro-inflammatory cells, it is likely that there is an
association between staphylococcal infection and the
pathogenesis of atopic diseases such as dermatitis, rhinitis
and asthma [7,8]. Enterotoxins produced by S. aureus and
their specific IgE antibodies are thought to be important
in worsening atopic dermatitis [7].
Studies have shown greater S. aureus colonisation in the
skin of patients with atopic eczema/dermatitis syndrome
(AEDS) (80–100%) than in the skin of normal healthy
subjects (5–30%). Indeed S. aureus constitutes up to 80%
of the normal flora in atopic individuals and S. aureus iso-
lated from the skin of at least 65% of AEDS patients
secretes the Sags, S. aureus enterotoxin A (SEA), S. aureus
enterotoxin B (SEB), S. aureus enterotoxin C (SEC), S.
aureus enterotoxin D (SED) and Toxic Shock Syndrome
Toxin-1 (TSST-1) [9].
In humans it is the nasal passage which is the most com-
mon site for S. aureus colonization [10]. Whereas more
than 50 % pathogenic isolates of S. aureus produce one or
more SAgs exotoxins, even strains isolated from asympto-
matic carriers can produce SAgs [11]. Given their anatom-
ical localization and ability to produce exotoxins, it is
likely that the nasal passage is exposed to bacterial SAgs
[1].
In comparison to AEDS, few studies have documented the
role of S. aureus or its SAgs in allergic or non-allergic air-
way disease. Earlier investigations suggested an allergy to
certain bacteria as an important cause of exacerbation of
the disease in patients suffering from allergic airway dis-
ease [12,13]. However, the tests used whole bacterial
lysates, were highly unspecific and no correlations were
found among these results.
Interferon-gamma (IFN-γ) is known to induce major his-
tocompatibility complex class II expression on bronchial
epithelial cells in vitro [14,15]. In vivo the expression of
MHC class II molecules is enhanced in asthma and lung
neoplastic disease, allowing bronchial epithelial cells to
function as antigen presenting cells and to interact with T
cells [15,16]. Although the major role of MHC class II is
to present antigens to T cells, engagement of MHC class II
by superantigens and other bacterial products has also
consequences for the class II expressing cells including
increased cytokine secretion and apoptosis [16-18].
Even though the MHC class II molecule appears to be the
major receptor for the staphylococcal enterotoxins, it has
been shown that antibodies to major histocompatibility
complex I (MHC class I) can inhibit the binding of SEA
and SEB to MHC class II negative macrophages [19]. Stud-
ies performed with MHC class II negative epithelial cell
line demonstrated modulation of intracellular Ca2+ signal
pathway in response to SEA [20]. These findings suggest
that MHC class II molecule may not be the only receptor
for staphylococcal exotoxins.
It has been recently demonstrated that interaction of live
S. aureus with human tracheal epithelial cell line MM-39
stimulates release of IL-8, eotaxin and RANTES [21]. Our
study investigates the effect of S. aureus products, SEA and
SEB, on human nasal epithelial cells and tests the hypoth-
esis that SEA and SEB can induce the release of proinflam-
matory cytokines from human nasal epithelial cells.
Materials and methods
Subjects were recruited from staff and students at Queen's
University Belfast or the Belfast City Hospital. The study
was approved by the Research Ethics Committee of
Queen's University Belfast and all participants provided
written informed consent. All subjects were non-smokers
and were between 22–39 years old. They were in good
general health and had no history of cardiac or renal dis-
ease.
Control subjects had no history of respiratory symptoms
and some were atopic. Asthmatic subjects had a clinical
history of physician-diagnosed asthma, with intermittent
shortness of breath or wheeze within the previous 12
months. All subjects had an FEV1 of at least 60% pre-
dicted. They were not taking regular anti-inflammatory
therapy and were maintained only on short-acting β2 ago-
nists. No subject had previously been prescribed a long
acting β2 agonist. They had not taken either inhaled or
oral steroids in the six months preceding the commence-
ment of the study. They had been free from upper respira-
tory tract infections for a minimum of four weeks
preceding the commencement of the study. Atopy was
defined by positive skin prick tests to 1 or more of 4 com-Respiratory Research 2006, 7:115 http://respiratory-research.com/content/7/1/115
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mon environmental allergens, including house dust mite
(Dermatophagoides pterynonisinus (HDM), mixed grass pol-
len, cat and dog hair. Standardised allergen preparations
(Dome-Hollister-Stier, Epernon Cedex, France) of house
dust mite (Dermatophagoides pterynonisinus) (HDM),
mixed grass pollen, cat and dog hair were applied to the
volar aspect of the forearm, using a standard puncture
technique as described by the European Academy of Aller-
gology and Clinical Immunology [22]. Standardised solu-
tions of histamine (1% w/v) and saline were used as
positive and negative controls respectively. Atopy was
defined as having one or more positive skin prick tests to
test allergen solutions.
Spirometry
Spirometry was performed on all subjects. Spirometry was
performed according to the American Thoracic Society
Guidelines using a Vitalograph spirometer [23]. Prior to
attending for spirometry, subjects were asked to withhold
short acting β2 acting agonists for at least eight hours.
Records were taken of the subjects' height, weight and age.
Predicted values for spirometry were then calculated from
validated equations [24].
Isolation of primary human nasal epithelial cells
Nasal brushings were performed on all subjects using a
standardized protocol and no local anaesthetics were used
during the procedure. A bronchial cytology brush
(TeleMed Systems Inc., MA, USA) was used to obtain two
brushings from the external turbinate of each nostril. Each
nostril was brushed once and the process was repeated
providing the subject tolerated the process.
Cells were cultured in BEGM medium (Clonetics) until
passage. Cells from passage 1 were frozen in liquid nitro-
gen and stored until used in experiments at passage 2–3.
All the cells used in this work stained positive with pan-
cytokeratine, cytokeratine 5+8, cytokeratin 8, cytokeratin
18 and negative with anti-vimentin and anti-cytokeratin
13 (not shown). Cells were grown in submersion cultures.
For the experiments, human nasal epithelial cells
(HNECs) were seeded into 24 well plates using a seeding
density of 2 × 105 cells/ml and a well volume of 300 μl.
Cells were incubated at 37°C, 5% CO2 for 6 h. After the 6
h incubation period the cells were washed with PBS
(37°C, pH 7.4) and fresh BEGM with or without 50 IU/ml
IFN-γ was added to the wells. Cells were left to incubate at
37°C for a further 24 h. After 24 h (cells 80–90% conflu-
ent), media was removed and the cells were washed with
PBS (37°C, pH 7.4) and fresh media added containing
either SEA or SEB (0.01 and 1 μg/ml) or nothing (con-
trol). Supernatants were collected 6 and 24 h post stimu-
lation and stored at -80°C until analysed by ELISA. In
selected experiments before enterotoxin stimulation
blocking anti-MHC class II antibody (IgG2a, clone L243,
BioLegend, San Diego, CA) was added at 50 μg/ml for 1
hour to cell cultures. After incubation enterotoxins were
added as described above. The concentration of antibody
used inhibited detection of MHC class II on human
monocytic THP-1 cell line by 95%. Purified mouse IgG2a
(MOPC-173, BioLegend) was used as control.
Spiking experiments
Nasal epithelial cells were seeded into 24-well plates using
a density of 2.5 × 105 cells/ml and a well volume of 300
μl. Cells were stimulated with either 1 μg/ml SEA or SEB.
The supernatant was collected at 24 h of culture. Spiking
was carried out by splitting the supernatant into two aliq-
uots. The first aliquot was spiked with 500 pg/ml of either
TNF-α, RANTES or eotaxin. Cytokine concentrations were
then measured by ELISA in both portions.
Cell lysate experiments
Once supernatants were collected, fresh BEGM (300 μl)
was added to each well. To lyse the cells the 24-well plate
was freeze-thawed three times. The lysate was then centri-
fuged at 300 g  for 5 min and subsequently aliquoted.
Cytokine concentrations in lysates were measured by
ELISA.
ELISA assay
Cytokine analyses were carried out using sandwich ELISA
according to manufacturer's instructions (R & D Systems).
Reagents
Recombinant IFN-γ was purchased from PeproTech EC
(London, UK). SEA and SEB were purchased from Sigma-
Aldrich (Poole, UK). SEA and SEB were used in concentra-
tions of 0.01 and 1 μg/ml which in preliminary experi-
ments have been shown to be non-toxic for epithelial cells
by MTT and trypan blue exclusion tests.
Flow cytometric analysis
Nasal epithelial cells were detached from culture dishes by
means of nonenzymatic cell dissociation solution
(Sigma) and were then stained with anti-HLA-DR, P, Q
FITC conjugated monoclonal antibody (DAKO). MHC
class II expression epithelial cells was assessed by flow
cytometry (EPICS II; Coulter, Hialeah, Fl). Results were
expressed as % of positive cells and as mean fluorescence
intensity.
Statistical analysis
Results are reported as median (range). Statistical compar-
isons were performed using Mann-Whitney U test, Fried-
man (Dunn's post-hoc test) and Wilcoxon matched pair
test. All statistical analyses were carried out using SPSS
(Version 11.5) for Windows and GraphPadPrism®. Graph-
PadPrism® was used to plot graphs.Respiratory Research 2006, 7:115 http://respiratory-research.com/content/7/1/115
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Results
Subject characteristics
A total of 20 subjects were included in the study (mean
age 26.95 ± 4.19 y, 10 female). Subject characteristics are
summarised in table 1.
Effect of Enterotoxin A (SEA) and Enterotoxin B (SEB) on 
primary human nasal epithelial cells
Basal release of IL-8
There was no significant difference in the baseline release
of IL-8 from non-stimulated cells derived from normal
(358.4 pg/ml, 304.2–509.6 pg/ml) and asthmatic subjects
(607.9 pg/ml, 424.9–717.4 pg/ml, p = 0.06) at 6 h. How-
ever, in contrast cells derived from asthmatic subjects
released significantly more IL-8 at 24 h compared to those
derived from control subjects (normal control 671.8 pg/
ml, 511.8–875.0 pg/ml; asthmatic 1239.0 pg/ml, 859.9–
1547 pg/ml, p = 0.03) (Figure 1).
Effect of IFN-γ on IL-8 release
IFN-γ pre-treatment (50 U/ml) of cells derived from nor-
mal subjects increased baseline IL-8 release significantly at
6 h (370.4 pg/ml, 320.6–528.6 pg/ml, p < 0.01) and 24 h
(694.4 pg/ml, 549.5–908.7 pg/ml, p < 0.01). Similarly, IL-
8 release from cells derived from asthmatic subjects was
increased significantly at 6 h (657.7 pg/ml, 453.5–749.0
pg/ml, p < 0.01) and 24 h (1304.0 pg/ml, 919.6–1645.0
pg/ml, p < 0.01) (Figure 1). Although there was no signif-
icant difference in the baseline release of IL-8 after IFN-γ
pre-treatment between cells derived from normal and
asthmatic subjects at 6 h (p > 0.05) the difference was sig-
nificant at 24 h (p = 0.02).
IL-8 release in response to SEA
SEA caused significant IL-8 release from nasal epithelial
cells derived from control and asthmatic subjects at both
6 and 24 h (both concentrations tested). The median val-
ues of IL-8 concentration were at 6 h incubation with 1.0
μg/ml SEA – 387.0 pg/ml, at 24 h incubation 848.8 pg/ml
for 0.01 μg/ml SEA and 923.7 pg/ml for 1.0 μg/ml SEA.
Cells derived from asthmatic subjects released signifi-
cantly more IL-8 than those from control subjects at both
6 h (p = 0.04) and 24 h (p = 0.02) (Figure 2 and 3). The
median value of IL-8 release for 6 hour stimulation with
0.01 μg/ml SEA was 710.9 pg/ml: for 24 hour stimulation
with 0.01 μg/ml SEA – 1035 pg/ml and with 1.0 μg/ml –
1367 pg/ml. Pretreatment of cells with IFN-γ (50 U/ml)
followed by toxin stimulation resulted in increased IL-8
release. In cells from healthy donors pretreated with IFN-
γ, SEA at 1.0 μg/ml induced release of 1009 pg/ml IL-8
(median value) while in cells from asthmatic donors the
same treatment induced significantly higher IL-8 secretion
– 1550 pg/ml (p = 0.04). (Figure 4 and 5).
IL-8 release in response to SEB
The highest concentration of SEB tested (1 μg/ml)
induced significant IL-8 release from cells derived from
normal and asthmatic subjects at both 6 and 24 h. The
median values of IL-8 release were 400.8 pg/ml for 6 hour
stimulation and 814.0 pg/ml for 24 hour stimulation. SEB
(1 μg/ml) induced significantly more IL-8 release from
Table 1: Subject Demographics
Patient ID Age (years) Sex Status Atopy FEV1 (L) FEV1 % pred FVC (L)
1 34 M Normal NA 4.5 110 6.2
3 25 M Normal A 4.6 108 5.7
4 27 M Normal NA 4.0 92 5.3
5 24 F Normal NA 3.4 103 3.6
6 25 M Normal NA 5.2 122 6.35
8 39 F Normal NA 2.6 116 3.3
9 25 F Normal A 3.6 100 4.0
10 23 F Normal A 3.2 98 3.3
14 27 M Normal NA 5.2 111 6.4
17 27 F Normal NA 3.1 98 4.1
2 32 M Asthmatic A 4.9 121 4.7
7 32 M Asthma A 4.5 82 6.4
11 27 M Asthmatic A 3.1 87 4.1
12 25 F Asthmatic A 3.1 97 3.7
13 24 F Asthmatic A 3.4 114 3.8
15 27 M Asthmatic NA 3.9 95 5.4
16 22 F Asthmatic A 2.9 102 3.6
18 25 M Asthmatic A 3.3 79 4.7
19 24 F Asthmatic A 2.9 94 3.4
20 25 F Asthmatic A 3.7 104 4.2
M = male, F = female; A = atopic, NA = non-atopic; FEV1 = forced expiratory volume in one second; FVC = forced vital capacity; L = litres.Respiratory Research 2006, 7:115 http://respiratory-research.com/content/7/1/115
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Release of interleukin-8 (IL-8) in cell culture supernatants after interferon-gamma (IFN-γ) pretreatment Figure 1
Release of interleukin-8 (IL-8) in cell culture supernatants after interferon-gamma (IFN-γ) pretreatment. Data are shown as 
individual points, the line represents the median. Black symbols = no IFN-γ pretreatment, open symbols = IFN-γ pretreatment. 
P values reaching statistical significance are marked on the graph. * = P < 0.05; ** = P < 0.01.
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Interleukin-8 (IL-8) release from cells derived from normal  subjects in response to SEA after 6 and 24 hour stimulation Figure 2
Interleukin-8 (IL-8) release from cells derived from normal 
subjects in response to SEA after 6 and 24 hour stimulation. 
Data are shown as individual points, the line represents the 
median. ■ = control (unstimulated cells), ▲ = 0.01 μg/ml 
SEA, ● = 1 μg/ml SEA. Median values of IL-8 release at 6 
hours: control P values reaching statistical significance are 
indicated on the graph.
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Interleukin-8 (IL-8) from cells derived from asthmatic sub- jects in response to SEA after 6 and 24 hour stimulation Figure 3
Interleukin-8 (IL-8) from cells derived from asthmatic sub-
jects in response to SEA after 6 and 24 hour stimulation. 
Data are shown as individual points, the line represents the 
median. ■ = control (unstimulated cells), ▲ = 0.01 μg/ml 
SEA, ● = 1 μg/ml SEA. P values reaching statistical signifi-
cance are indicated on the graph.
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cells derived from asthmatic subjects compared to cells
derived from normal subjects at 6 and 24 h (p = 0.02 and
0.01 respectively) The median values of IL-8 release from
asthmatic cell cultures were 737.9 pg/ml for 6 hour and
1493.0 pg/ml for 24 hour stimulation (Figure 6 and 7).
Pretreatment of cells with IFN-γ followed by toxin stimu-
lation resulted in increased IL-8 release. Normal cells pre-
treated with IFN-γ and then cultured with SEB at 1.0 μg/
ml released 904.6 pg/ml IL-8 (median value). Cells from
asthmatics treated in the same way produced significantly
higher amounts of IL-8 – 1665.0 pg/ml (p = 0.01) (Figure
8 and 9).
TNF-α, RANTES and eotaxin release
Recent studies performed with S.aures added to airway
epithelial cell culture have demonstrated robust response
Interleukin-8 (IL-8) release from cells derived from asthmatic  subjects in response to SEB after 6 and 24 hour stimulation Figure 7
Interleukin-8 (IL-8) release from cells derived from asthmatic 
subjects in response to SEB after 6 and 24 hour stimulation. 
Data are shown as individual points, the line represents the 
median. ■ = control (unstimulated cells), ▲ = 0.01 μg/ml 
SEB, ● = 1 μg/ml SEB. P values reaching statistical signifi-
cance are indicated on the graph.
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Interleukin-8 (IL-8) release from interferon-gamma (IFN-γ)- treated cells derived from asthmatic subjects in response to  SEA after 6 and 24 hour stimulation Figure 5
Interleukin-8 (IL-8) release from interferon-gamma (IFN-γ)-
treated cells derived from asthmatic subjects in response to 
SEA after 6 and 24 hour stimulation. Data are shown as indi-
vidual points, the line represents the median. ■ = control 
(unstimulated cells), ▲ = 0.01 μg/ml SEA, ● = 1 μg/ml SEA. P 
values reaching statistical significance are indicated on the 
graph.
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Interleukin-8 (IL-8) release from interferon-gamma (IFN-γ)- treated cells derived from normal subjects in response to  SEA after 6 and 24 hour stimulation Figure 4
Interleukin-8 (IL-8) release from interferon-gamma (IFN-γ)-
treated cells derived from normal subjects in response to 
SEA after 6 and 24 hour stimulation. Data are shown as indi-
vidual points, the line represents the median. ■ = control 
(unstimulated cells), ▲ = 0.01 μg/ml SEA, ● = 1 μg/ml SEA. P 
values reaching statistical significance are indicated on the 
graph.
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Interleukin-8 (IL-8) release from cells derived from normal  subjects in response to SEB after 6 and 24 hour stimulation Figure 6
Interleukin-8 (IL-8) release from cells derived from normal 
subjects in response to SEB after 6 and 24 hour stimulation. 
Data are shown as individual points, the line represents the 
median. ■ = control (unstimulated cells), ▲ = 0.01 μg/ml 
SEB, ● = 1 μg/ml SEB. P values reaching statistical signifi-
cance are indicated on the graph.
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by secretion of proinflammatory cytokines including
RANTES and eotaxin [21]. In our experiments TNF-α,
RANTES and eotaxin were not detectable in cell culture
supernatants collected at 6 and 24 h post stimulation with
SEA or SEB. The detection limit for these assays was 2 pg/
ml (data not shown).
Spiking experiments
In order to ascertain that inability to detect RANTES, TNF-
α and eotaxin was not due to fast degradation of cytokines
in culture supernatant, spiking experiments were per-
formed as described in Materials and Methods. Results
obtained from these experiments showed that TNF-α was
fully recoverable from all supernatants measured, whilst
90.8 ± 7.6% of IL-8, 74 ± 8.1 % of RANTES and 86.5 ± 7.7
% of Eotaxin was recoverable as measured by ELISA.
Cell associated cytokines
In order to establish whether cytokines under study were
stored intracellularly and failed to be secreted, we meas-
ured their concentration in cell lysates obtained from
unstimulated cells and cells stimulated with enterotoxins.
IL-8 was present in cell lysates from stimulated cells and
was not detected in lysates from unstimulated cultures.
TNF-α, RANTES and eotaxin were not detected in any of
the patients' cell lysates (data not shown).
HLA class II expression on nasal epithelial cells
Flow cytometric analysis of class II molecules expression
revealed that only a small proportion of cells both from
normal and asthmatic subjects were class II positive
(healthy 2.5% ± 0.63, mean fluorescence (mf) 205 ± 40,
asthmatics 2.03% ± 0.47, mf 193.8 ± 37.2). After stimula-
tion with IFN-γ there was a small increase in percentage of
HLA class II positive cells (healthy 10.2% ± 2.96, mf 1145
± 301; asthmatics 11.76% ± 1.87, mf 1013 ± 189). No sig-
nificant difference between cells from normal and asth-
matic subjects was observed both under basal and
stimulated conditions (p < 0.01). (Table 2)
Involvement of MHC class II molecules in stimulation of
HNEC by SEA and SEB.
Normal HNEC (n = 5) were pretreated for 24 h with 50 IU
of IFN-γ/ml (or left untreated for control HNEC) and then
were incubated with SEA or SEB (1 μg/ml) in the presence
or absence of anti-MHC class II blocking antibody (50 μg/
ml) as described in Material and Methods. Determination
of IL-8 concentration in culture supernatants revealed that
Table 2: Flow cytometric analysis of HLA class II expression on 
nasal epithelial cells.
Human nasal epithelial cells % positive Mean fluorescence
Normal 2.5 ± 0.63 205 ± 40
Normal + IFN-γ 10.2 ± 2.69 1145 ± 301
Asthmatic 2.03 ± 0.47 193 ± 37
Asthmatic + IFN-γ 11.76 ± 1.87 1013 ± 189
Nasal epithelial cells were detached from culture dishes by means of 
nonenzymatic cell dissociation solution and were then stained with 
anti-HLA-DR, P, Q, FITC-conjugated monoclonal antibody. Membrane 
fluorescence was analysed by flow cytometry.
Interleukin-8 (IL-8) releases from interferon-gamma (IFN-γ)- treated cells derived from normal subjects in response to  SEB after 6 and 24 hour stimulation Figure 8
Interleukin-8 (IL-8) releases from interferon-gamma (IFN-γ)-
treated cells derived from normal subjects in response to 
SEB after 6 and 24 hour stimulation. Data are shown as indi-
vidual points, the line represents the median. ■ = control 
(unstimulated cells), ▲ = 0.01 μg/ml SEB, ● = 1 μg/ml SEB. P 
values reaching statistical significance are indicated on the 
graph.
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Interleukin-8 (IL-8) release from interferon-gamma (IFN-γ)- treated cells derived from asthmatic subjects in response to  SEB after 6 and 24 hours stimulation Figure 9
Interleukin-8 (IL-8) release from interferon-gamma (IFN-γ)-
treated cells derived from asthmatic subjects in response to 
SEB after 6 and 24 hours stimulation. Data are shown as indi-
vidual points, the line represents the median. ■ = control 
(unstimulated cells), ▲ = 0.01 μg/ml SEB, ● = 1 μg/ml SEB. P 
values reaching statistical significance are indicated on the 
graph.
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IL-8 secretion induced by SEA was inhibited by 40.5 ± 3.2
% in IFN-γ unstimulated cultures and by 70.2 ± 5.1 %
IFN-γ treated cultures. For SEB stimulated cultures the
obtained values showed 42.5 ± 3.2% and 68.9 ± 4.5%.
These results indicate at least partial involvement of MHC
class II molecules in SEA and SEB induced secretion of IL-
8 from HNEC.
Discussion
The main finding of this study is that SEA and SEA in non
toxic concentrations directly stimulate nasal epithelial
cells to produce IL-8 while they have no effect on TNF-α,
RANTES and eotaxin production. These four cytokines
have pivotal roles in the inflammatory response in the
lung. IL-8 and eotaxin act as chemoattractants for neu-
trophils [25-27] and eosinophils [28] while RANTES is a
chemoattractant for many inflammatory cells including
eosinophils [29] and T lymphocytes [30]. TNF-α is a mul-
tifunctional cytokine which is known not only to stimu-
late most cell types to release other cytokines including
GM-CSF [31] but is also known to stimulate the produc-
tion of cytotoxic oxygen metabolites from eosinophils
[32].
Since increased concentrations of IFN-γ are present in
inflamed airways, the effect of preincubating cells with
IFN-γ (50 IU/ml) prior to SAg stimulation was also inves-
tigated. IFN-γ has many proinflammatory effects and has
been shown to play an important role in early childhood
asthma through the upregulation of ICAM-1 [33] and the
cellular receptor for TNF-α [34]. Other studies have dem-
onstrated increased IFN-γ in BAL and blood from atopic
asthmatics including acute severe asthmatics [35-37]. It is
conceivable then that increased levels of IFN-γ in asth-
matic airways result in upregulation of MHC class II
expression seen in asthmatic airway epithelium [38]. In
this study, cells from both subject groups were incubated
with IFN-γ prior to toxin stimulation to investigate what
effect if any there was on the release of IL-8.
Cells derived from normal subjects released IL-8 at 6 and
24 h in response to both SEA and SEB, with significantly
increased responses in cells from asthmatic patients. Pre-
treatment of normal cells with IFN-γ followed by toxin
stimulation resulted in increased IL-8 release. A similar
trend was observed in IL-8 release from cells derived from
asthmatic donors. IFN-γ pretreated cells derived from
asthmatic subjects released increased levels of IL-8 in
response to SEA (0.01 μg/ml) and SEB (1 μg/ml) at 6 h
while at 24 h there was significant increase in IL-8 in
response to both concentrations of SEA and to 1 μg/ml
SEB.
The mechanism of how staphylococcal enterotoxins acti-
vate cells has been linked to their ability to crosslink the
MHC class II molecules. The presence of HLA-DR antigens
was demonstrated on IFN-γ treated airway epithelial cells
but very little on unstimulated cells [39]. We also demon-
strate that MHC class II antigen expression on HNEC can
be upregulated by incubation with IFN-γ. The induced
increase is however of moderate magnitude not exceeding
15% of cultured cells. No significant differences between
normal and asthmatic HNEC were noted. Despite modest
expression of MHC class II molecules on epithelial cell
membrane, addition of blocking anti-HLA-DR antibody
decreased IL-8 secretion in cultures of HNEC (40% reduc-
tion in unstimulated cells and 70.2% reduction in IFN-γ
stimulated cells). These results indicate that enterotoxin
binding to MHC class II receptors is at least partially
responsible for the observed increase in IL-8 secretion.
Similar study using HNEC has recently been published
showing that SEB induces proinflammatory cytokine
secretion in vitro [40]. This study however did not inves-
tigate MHC class II expression and did not attempt to
characterise the receptor responsible for SEB binding.
Some of the recent studies have shown that not all effects
exerted by SAgs can be attributed to class II binding and
crosslinking. Arad et al. showed that all superantigens
have the ability to stimulate cross-immunity against each
other through interaction of a dodecapeptide region of
the molecules with a host cell receptor not involving MHC
class II or T cell receptor [41]. Later Shupp and colleagues
suggested that this receptor was important for superanti-
gen transcytosis across mucosal surfaces [42] The staphy-
lococcal enterotoxins which are members of the SAgs
family have receptors on intestinal cells that lead to eme-
sis and diarrhea associated with food poisoning; these
biological effects are independent of superantigenicity
[43,44]. While these results do not rule out direct effect of
these toxins on intestinal epithelium they show that tox-
ins can gain rapid access to the immune system. Further
studies in this area using polarized nasal epithelial cells
are clearly warranted. Finally, Paterson et al. showed that
TSST-1 stimulates human vaginal epithelial cells to chem-
okine production via non MHC class II receptor [45]. It is
therefore conceivable that interaction of SEA and SEB with
nasal epithelial cells leading to IL-8 secretion described
here can be mediated not only by MHC class II molecules
but also by other yet undefined receptor and the effects
described in this paper are due to enterotoxin binding to
both MHC and non MHC receptors. It is also difficult to
explain higher secretion of IL-8 from asthmatic HNEC in
comparison to epithelial cells from normal cells since
both groups expressed similar level of MHC class II mole-
cules. We can only speculate that other, yet undefined
receptor is responsible for this effect. This clearly requires
further investigation.Respiratory Research 2006, 7:115 http://respiratory-research.com/content/7/1/115
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Specific IgE to S. aureus SAgs is present in nasal polyp tis-
sue, and levels correlate with markers of eosinophil acti-
vation and recruitment [46]. SEB selectively stimulates the
production of interleukin-5 (IL-5) in patients with atopic
eczema/dermatitis syndrome (AEDS) or allergic asthmat-
ics but not in asymptomatic atopic or non-atopic individ-
uals [6]. Given the central role of IL-5 in eosinophilia this
provides further evidence that SEB may at least, play some
role in allergic diseases such as AEDS and asthma. Further
evidence that SAgs may play an important role in allergic
diseases such as dermatitis, rhinitis and asthma comes
from studies which report the prevalence of serum IgE
antibodies to S. aureus enterotoxins. Sensitisation to S.
aureus  enterotoxins seems to be a factor in increasing
serum eosinophil cationic protein (ECP) which is thought
to be a reliable marker of clinical severity of allergic dis-
eases including asthma and rhinitis [47].
As part of this study cell culture supernatants collected 6
and 24 h post SAg stimulation were analysed for TNF-α,
RANTES and eotaxin. However, in all 20 subject samples
these mediators were not detectable. In vivo administra-
tion of SEB to mice has been shown to trigger an inflam-
matory response characterised by mucosal and airway
recruitment of lymphocytes, eosinophils and neutrophils
together with elevated levels of IL-4 in BAL fluid [48]. The
same study also demonstrated that SEB markedly
enhances the frequency detection of TNF-α in BAL fluid
[49]. However extrapolating results from animal studies
and relating them to human studies must be done so with
caution. It has been documented that murine cells are up
to 1000 times less responsive to S. aureus enterotoxins
than human cells [50].
Release of RANTES in response to SEB has been demon-
strated in the human colonic T84 epithelial cell line [51].
In a model of human fibroblast-like synoviocytes, engage-
ment of MHC class II molecules by SEA resulted in an
increase in the mRNA level and protein synthesis of
RANTES and IL-8 [52] while stimulation of human
PBMCs to release RANTES in response to SEB has also
been demonstrated [53].
In the human system of polarized bronchial epithelial
cells a marked alteration in the transcriptional expression
profile of epithelial cells in response to live S. aureus and
soluble virulence factors was observed. These included
pro-inflammatory cytokine release such as IL-1β, IL-8,
eotaxin and RANTES [21,54]. It is possible that a mixture
of soluble virulence factors induces vigorous proiflamma-
tory cytokine response as a result of synergistic action of
many bacterial products including exotoxins. Further
studies using polarised HNEC should clarify the issue.
In conclusion this study indicates that SEA and SEB can
induce an inflammatory response in human nasal epithe-
lial cells. The responses to SEA and SEB are higher in asth-
matic subjects and can be further elevated by
preincubaion with IFN-γ. This would suggest that bacte-
rial toxins such as SEA and SEB may play a role in the
pathogenesis of asthma possibly via the recruitment of
neutrophils into the asthmatic airway.
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